System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Charles B Simone is an expert in Oncology at Memorial Sloan Kettering Cancer Center (United States). As of October 2026, ScienceLeadR ranks Charles B Simone in the top 1% of experts worldwide for Thoracic Neoplasms, Lung Neoplasms and Bronchial Neoplasms. Charles B Simone has authored 819 publications, the most recent in 2027, and is an investigator in 20 clinical trials, 7 of them ongoing. SLR score: 2,938 (community average: 125). How the SLR is computed.

LeadR Profile

Charles B Simone Memorial Sloan Kettering Cancer Center United States
2 938 ScienceLeadR Reputation 2938

Unlock

Register Login
Network Map

Oncology

Subspecialties: Radiotherapy - Palliative Medicine - Nuclear Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2008 - 2027
Source: PubMed

New York Proton Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 819

Citations

Citations: 19 170 1st author: 46 Last author: 211 Unique author: 70

Main journals

Ann Palliat Med 115
Int J Radiat Oncol Biol Phys 112
J Thorac Oncol 37
Radiother Oncol 37
J Clin Oncol 32

Best Journals

J Clin Oncol 21
Lancet Oncol 7
JAMA Oncol 4

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Image-Guided Decubitus Craniospinal Irradiation Setup in a Fixed-Beam Proton Room: Accuracy and Efficiency.
PMID 42898231 — craniospinal irradiation, workflow, therapeutics		Int J Part Ther20260
Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial.
PMID 42844242 — radiotherapy, cells, confidence intervals, lung, neutropenia, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, small cell lung carcinoma		Nat Commun20260
Development and Validation of a Tool to Measure Documented Health Care Encounter Time.
PMID 42848401 — neoplasms, clinical medicine, records, therapeutics, medical records		JAMA Netw Open20260
Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.
PMID 42702214 — radiotherapy, cells, lung, neoplasms, carcinoma, non-small-cell lung, drug-related side effects and adverse reactions, lung neoplasms, small cell lung carcinoma, therapeutics		Lancet Top journal20261
Hypofractionated and stereotactic body proton radiotherapy for a high-risk lung cancer cohort: A multi-institutional experience from the proton collaborative group prospective registry.
PMID 42787797 — registries, radiotherapy, proton therapy, lung, neoplasms, multiple chronic conditions, lung neoplasms, therapeutics		Clin Transl Radiat Oncol20260

Clinical Studies 20

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 2 8
N/A 4
Phase 1/Phase 2 3
Phase 3 3
Phase 1 2

By status:

Completed 7
Recruiting 5
Active not recruiting 4
Terminated 2
Unknown 2

By type:

Interventional 19
Observational 1

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 5
multicentric5to9 4
multicentricup10 4

Main Topics

Ongoing Clinical Trials

7 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of Ivonescimab in People With Non Small Cell Lung Cancer
NCT07594522 — radiotherapy, cells, proton therapy, lung, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, small cell lung carcinoma, institutional practice, therapeutics, carcinoma		Phase 1/Phase 2Recruiting2026
A Study of Targeted Post Surgery Radiation Therapy for Non Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
NCT07293247 — radiotherapy, intensity-modulated, radiotherapy, cells, lung, blood, lymph nodes, pharmaceutical preparations, tomography, lymphadenopathy, positron-emission tomography, neoplasms, carcinoma, non-small-cell lung, magnetic resonance imaging, carcinoma, small cell, drug therapy, immunotherapy, aftercare, fluorodeoxyglucose f18, lung neoplasms, lymph, small cell lung carcinoma, neoadjuvant therapy, specimen handling, therapeutics, chemotherapy, carcinoma		Phase 2Recruiting2026
Testing the Addition of High Dose Targeted Radiation to the Usual Treatment for Locally Advanced Inoperable Non Small Cell Lung Cancer
NCT05624996 — radiotherapy, radiotherapy, image-guided, taxes, cells, research design, albumin-bound paclitaxel, folic acid antagonists, pemetrexed, lung, growth, radiosurgery, paclitaxel, nanoparticles, pharmaceutical preparations, tomography, disulfides, positron-emission tomography, antineoplastic agents, neoplasms, carcinoma, non-small-cell lung, carcinoma, small cell, drug therapy, positron emission tomography computed tomography, immunoglobulins, immunotherapy, lung neoplasms, small cell lung carcinoma, work, therapeutics, diamines, tissues, etoposide, carboplatin, dna, glucosides, immunoglobulin g, chemotherapy, carcinoma		Phase 3Recruiting2023
Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Radiotherapy Related Neuropathic Pain
NCT05543239 — vagus nerve stimulation, radiotherapy, skin, safety, pain, multiple chronic conditions, sensation, electrodes, ear, vagus nerve, head and neck neoplasms, neuralgia, pulse		N/ARecruiting2022
FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax
NCT05524064 — radiotherapy, pain, neoplasm metastasis, therapeutics, bone and bones		N/AActive not recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS